Satsuma Pharmaceuticals, Inc.
STSADelisted Jun 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001692830
Satsuma Pharmaceuticals, Inc. was delisted on Jun 8, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 31 institutions reported holding it in 13F filings for Q1 2023, worth $12.7M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Satsuma Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 36 | 32 | −4 |
| Shares | 23.1M | 22.8M | −312.4K (−1.4%) |
| Value | $87.7M | $94.2M | +$6.56M (+7.5%) |
New holders (3)
Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 46,998 | $195.0K | 0.00% |
| Citigroup Inc | 7,073 | $29.0K | 0.00% |
| Advisor Group Holdings, Inc. | 1,000 | $4.00K | 0.00% |
Sold out (7)
Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Ghost Tree Capital, LLC | 473,562 | $1.80M |
| Susquehanna International Group, LLP | 81,739 | $311.0K |
| Russell Investments Group, Ltd. | 69,351 | $263.0K |
| FMR LLC | 2,163 | $8.00K |
| Tower Research Capital LLC (TRC) | 1,782 | $7.00K |
| Royal Bank of Canada | 93 | $0 |
| Simplex Trading, LLC | 174 | $0 |